Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27916922 | 0.89 | TRPA1 (0.50) | TRPA1TRPV1 | |
| Bromide SCHEMBL10663202 | 0.85 | TRPA1 (0.47) | TRPA1TRPV1 | |
| Methane SCHEMBL28183915 | 0.85 | TRPA1 (0.47) | TRPA1TRPV1 | |
| Hydrochloric Acid SCHEMBL1353085 | 0.85 | TRPA1 (0.47) | TRPA1TRPV1 | |
| Methylene Chloride SCHEMBL27587026 | 0.76 | TRPA1 (0.40) | TRPA1TRPV1 | |
| SCHEMBL7642243 | 0.76 | TRPA1 (0.40) | TRPA1TRPV1 | |
| SCHEMBL332543 | 0.74 | — | — | |
| SCHEMBL28028751 | 0.73 | TRPA1 (0.38) | TRPA1TRPV1 | |
| 1,2-Dichloroethane SCHEMBL28285011 | 0.73 | TRPA1 (0.38) | TRPA1TRPV1 | |
| SCHEMBL9498704 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107406837-A | DNA enzymatic of modification and application thereof | 波塔力克斯有限公司 | 2017-11-28 | — | — | CN | disclosed |
| EP-2565205-B1 | GLUCAGON-LIKE PEPTIDE-1 ANALOGUE AND USE THEREOF | BETTA PHARMACEUTICALS CO LTD (CN) | 2015-07-01 | — | — | EP | disclosed |
| US-8951959-B2 | Glucagon-like peptide-1 analogues and uses thereof | BETTA PHARMACEUTICALS CO., LTD. (CN) | 2015-02-10 | — | — | US | disclosed |
| EP-2565205-A1 | GLUCAGON-LIKE PEPTIDE-1 ANALOGUE AND USE THEREOF | Zhejiang Beta Pharma Inc. (CN) | 2013-03-06 | — | — | EP | disclosed |
| US-20130053304-A1 | GLUCAGON-LIKE PEPTIDE-1 ANALOGUES AND USES THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053304-A1 | GLUCAGON-LIKE PEPTIDE-1 ANALOGUES AND USES THEREOF | GLP1R, GCG, IAPP | TRPA1 4759/4885TRPV1 3895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.